CD40 Antikörper
Kurzübersicht für CD40 Antikörper (ABIN7828766)
Target
Alle CD40 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Verwendungszweck
- Purified Anti-Mouse CD40 Antibody[3/23]
-
Aufreinigung
- >98%, Protein A/G purified
-
Reinheit
- >98 %
-
Immunogen
- Recombinant Mouse CD40 protein
-
Isotyp
- IgG2a, kappa
-
-
-
-
Applikationshinweise
- FCM 2 μg/mL(0.5x106-1x106 cells)
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Konzentration
- ≥ 1 mg/mL
-
Buffer
- Phosphate-buffered solution, pH 7.2, containing 0.05 % non-protein stabilizer. Dialyze to completely remove the stabilizer prior to labeling.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Store at 4°C valid for 12 months or -20°C valid for long term storage, avoid freeze / thaw cycles.
-
Haltbarkeit
- 12 months
-
-
- CD40
-
Andere Bezeichnung
- CD40
-
Hintergrund
- CD40 (protein),CD40 Molecule,CDW40,IMD,B-cell surface antigen CD,Tumor necrosis factor receptor superfamily member,HIGM,Tnfrsf,HIGM1,I326936,IGM,IMD3,p50,T-BAM,TRAP,Bp50,CD40,Tnfrsf5,Tumor necrosis factor receptor superfamily member 5,B-cell surface antigen CD40,CD40L receptor,gp39 R,TNFRSF5,CD40 is a type I transmembrane glycoprotein belonging to the TNF receptor superfamily. The mature mCD40 consists of a 172 amino acid (aa) extracellular domain, a 22 aa transmembrane region and a 90 aa cytoplasmic domain . CD40 is expressed on B cells, follicular dendritic cells, dendritic cells, activated monocytes, macrophages, endothelial cells, vascular smooth muscle cells and several tumor cell lines. Cat.No. Product Name Clone No. E-AB-F1028A Purified Anti-Mouse CD40 Antibody[FGK4.5/FGK45] FGK4.5/FGK45 IF:{{item.impact}} Journal:{{item.journal}} ({{item.year}}) DOI:{{item.doi}} Reactivity:{{item.species}} Sample Type:{{item.sample_type}} Previous {{ page }} Next Q{{(FAQpage.currentPage - 1)*pageSize+index+1}}:{{item.name}} Previous {{ page }} Next [
-
UniProt
- P27512
-
Pathways
- NF-kappaB Signalweg, Cellular Response to Molecule of Bacterial Origin, M Phase, Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Production of Molecular Mediator of Immune Response, Cancer Immune Checkpoints
Target
-